As an original sponsor of the National Academy of Medicine’s Action Collaborative on Clinician Well-Being and Resilience, ASHP is proud to represent pharmacy in interprofessional efforts to address this critical workforce and patient care issue. Join ASHP’s Christina Martin, Director of New Practitioners Forum, and Anna Legreid Dopp, Senior Director of Clinical Guidelines and Quality Improvement, as they review key 2020 updates to ASHP and NAM well-being initiatives and highlight resources to support and care for the pharmacy workforce through COVID-19.
SPEAKERS
Anna Dopp, Pharm.D.,serves as the Senior Director of Clinical Guidelines and Quality Improvement at ASHP. Prior to this role, Dr. Dopp served as the Vice President of Public Affairs for the Pharmacy Society of Wisconsin while practicing as a clinical pharmacist at the University of Wisconsin Hospital and Clinics. She also served as a Pharmacy Benefit Consultant with WEA Trust in Madison, WI and a Clinical Assistant Professor at the University of Wisconsin-Madison School of Pharmacy. Dr. Dopp received her Doctor of Pharmacy from the University Of Minnesota College Of Pharmacy and served as a Congressional Health Policy Fellow with the United States Senate.
Christina Y. Martin, Pharm.D., M.S., is the Director of Membership Forums. In this role, Dr. Martin leads the development and implementation of strategies and programs for student and new practitioner members. Dr. Martin received her Pharm.D. from the University of Pittsburgh before completing a combined PGY1/PGY2 Health-System Pharmacy Administration residency at the University of Kansas Hospital. Dr. Martin holds a Master of Science degree in Pharmacy Practice from the University of Kansas. Dr. Martin is an active member of the American Society of Association Executives, currently serving on the Young Professional Committee.
